ADMA Biologics, Inc., a commercial biopharmaceutical company dedicated to specialty plasma-derived biologics, was granted FDA approval for its in-house aseptic fill-finish machine, the VanRx SA25.   The VanRx fill-finish machine uses a state-of-the-art closed isolator design and has the capability of rapidly switching between different container and closure formats, enabling aseptic filling in a variety of different fill volumes and presentation sizes. The combination of the FDA-approved incre...